AI applied to an electrocardiogram (EKG) test reliably detected asymptomatic left ventricular dysfunction (ALVD)—a precursor to heart failure—and predicted which patients were most at risk of developing the condition in the future, according to a Mayo Clinic study.
GE Healthcare and the Vanderbilt University Medical Center (VUMC) have partnered to develop diagnostic tools and AI-powered applications to create safer and more precise immunotherapy treatments for cancer patients.
An Atlanta research team has developed a smartphone app that can screen for anemia just by taking a picture of a person’s fingernails—paving the way for a new, noninvasive method to detect and diagnose the condition.
Cardiologs co-founder and CEO Yann Fleureau was named the European Innovator of the Year by MIT Technology Review, which also included the French native on its list of the top 35 European innovators under the age of 35.
The FDA is speeding up the review process for new software that uses AI to help radiologists diagnose chronic thromboembolic pulmonary hypertension (CTEPH), pharmaceutical company Bayer announced Dec. 3.
A deep-learning algorithm was significantly faster and just as accurate as most radiologists in analyzing chest X-rays for several diseases, according to a study led by Stanford University researchers.
An AI-based network outperformed several dermatologists while analyzing skin lesions for cancer, suggesting the technology could be a helpful tool for physicians regardless of their experience, according to a recent study.
Saint Thomas Health, a Tennessee-based health system, is the first in the state to use an AI-based software system that helps clinicians better diagnose and treat coronary artery disease, according to an online report by WGNS News Radio.